New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Study shows uninsured gig workers are unaware of affordable health insurance options
-
Lumos Pharma Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
-
Lumos Pharma Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
-
Form 4 Robinhood Markets, Inc. For: Aug 02 Filed by: New Enterprise Associates 17, L.P.
-
Metromile, Inc (MILE) Appoints John Butler and Sandra Clarke to its Board
-
Metromile Bolsters Board of Directors with Insurance and Finance Veterans
-
Metromile Bolsters Board of Directors with Insurance and Finance Veterans
-
Lumos Pharma, Inc. (LUMO) Announces Industry Veteran, David B. Karpf, MD, has Joined the Company as Chief Medical Officer
-
Lumos Pharma Announces Industry Veteran, David B. Karpf, MD, has Joined the Company as Chief Medical Officer
-
Lumos Pharma Announces Industry Veteran, David B. Karpf, MD, has Joined the Company as Chief Medical Officer
-
Lumos Pharma, Inc. (LUMO) Announces the Promotion of COO and Chief Scientific Officer, John McKew, PhD, to President
-
Lumos Pharma Announces the Promotion of COO and Chief Scientific Officer, John McKew, PhD, to President
-
Lumos Pharma Announces the Promotion of COO and Chief Scientific Officer, John McKew, PhD, to President
-
Syneos Health and Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization
-
Syneos Health and Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization
-
Form 3 Robinhood Markets, Inc. For: Jul 29 Filed by: New Enterprise Associates 17, L.P.
-
Lumos Pharma Appoints Pediatric Endocrinologist Experienced in Clinical Research and Pharmaceutical Development, Mark Bach, M.D., Ph.D., to Clinical Scientific Advisory Board
-
Lumos Pharma Appoints Pediatric Endocrinologist Experienced in Clinical Research and Pharmaceutical Development, Mark Bach, M.D., Ph.D., to Clinical Scientific Advisory Board
-
Reflecting on COVID-19 Innovation: Northwell Health Hosts Fourth Annual Constellation Forum
-
Form SC 13D Bright Health Group Inc. Filed by: New Enterprise Associates 17, L.P.
-
IonQ Positions Itself for Continued Industry Leadership with a String of Strategic Hires
-
Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021
-
Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021
-
Gig workers getting better health insurance at half the cost; 40% paying less than $1 per month.
-
Mobile And Web Brokerage Nvstr Rebrands As Tornado Empowering Smarter Investing Decisions For Anyone Who Aspires To Become A Better Investor
-
Lumos Pharma (LUMO) issues new guidance concerning the Phase 2 OraGrowtH210 Trial of LUM-201 in PGHD
-
Lumos Pharma Announces Clinical Updates
-
Lumos Pharma Announces Clinical Updates
-
Strive Health Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance
-
HEP Announces Five Realizations and New Investment
-
CIT GAP Funds Makes Follow-On Investment in SCOUT to Continue Performing In-Space Inspections on Satellites
-
Mobile Payments Leader, Slide, Introduces Unique In-App Shopping Experience Providing 4-5% Cash Back
-
Shape Therapeutics Secures $112 Million in Series B Financing to Advance Breakthrough RNA Technology Platforms to Democratize Gene Therapy
-
Shape Therapeutics Secures $112 Million in Series B Financing to Advance Breakthrough RNA Technology Platforms to Democratize Gene Therapy
-
Form SC 13D CVRx, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
OmniSci Promotes Pey Silvester to Vice President of Engineering
-
Battery-less Solutions Flood In, Explores IDTechEx
-
Topia Talent Mobility Platform Now Available on the SAP® Store
-
Form SC 13D Monte Rosa Therapeutics, Filed by: New Enterprise Associates 17, L.P.
-
Aetion and Cegedim Health Data Announce Long-Term Partnership to Expand Real-World Evidence Research in Europe
-
Aetion and Cegedim Health Data Announce Long-Term Partnership to Expand Real-World Evidence Research in Europe
-
Conviva Care Centers Expands Relationship with Strive Health to Provide Kidney Disease Care Management to Patients in Central and Northern Florida
-
Form 4 CVRx, Inc. For: Jul 02 Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Vori Health Raises Additional Capital from Strategic Partners Intermountain Healthcare, Ascension Ventures, and Echo Health Ventures
-
Robinhood reveals breakneck growth, legal pitfalls in IPO filing
-
Form 4 Bright Health Group Inc. For: Jun 28 Filed by: New Enterprise Associates 15, L.P.
-
Everside Health Announces Four Appointments to Board of Directors
-
Form 3 CVRx, Inc. For: Jun 29 Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
VistaGen Therapeutics Reports Fiscal Year 2021 Financial Results and Provides Corporate Update
-
VistaGen Therapeutics Reports Fiscal Year 2021 Financial Results and Provides Corporate Update

